GlaxoSmithKline [NYSE:GSK] said that findings from an interim analysis of RECORD (Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of glycemia in Diabetes), a prospective clinical trial designed specifically to determine cardiovascular outcomes in more than 4,400 patients with type 2 diabetes, adds further evidence to the overall cardiovascular safety profile of Avandia? (rosiglitazone maleate).
Paying hospitals extra money does not appear to significantly improve the way they treat heart attack patients or how well those patients do. But giving hospitals the information that they need to improve heart attack care does help.
University of Leeds scientists have shown how stroke victims could be more vulnerable to Alzheimer’s disease ? years or even decades after making a full recovery.
Januvia (scientific name sitagliptin), a new drug designed to improve blood sugar control in patients with type 2 diabetes, should not be used because the drug?s long-term safety is still unknown, Public Citizen writes in a new June posting on its WorstPills.org Web site.
Presbyterian Hospital/Columbia University Medical Center now offers patients a unique new hybrid imaging system that expands diagnostic and screening capabilities by combining nuclear cardiology with multi-slice CT imaging in one scanner.
Researchers have found that patients with obstructive sleep apnea (OSA) have higher levels of a type of dead cells (apoptotic cells) from the lining (endothelium) of their blood vessels circulating in their bloodstream than people who do not have OSA.
New findings show that the majority of people untrained in how to perform cardiopulmonary resuscitation, and even many trained emergency personnel, do not push with enough force to properly administer CPR.
Obesity is a risk factor for many serious illnesses including heart disease, type-2 diabetes, hypertension, stroke, and certain types of cancer. Child obesity is of particular concern.
The general public are worryingly ignorant about the symptoms and risk factors that contribute to serious medical conditions such as stroke and HIV/AIDS, according to a study published in the online open access journal BMC Medicine.
GlaxoSmithKline (GSK) confirms that a letter to the editor summarising additional Avandia cardiovascular safety data from several large-scale clinical trials was published online today in The Lancet.